471 related articles for article (PubMed ID: 25319699)
1. Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.
Balducci C; Mancini S; Minniti S; La Vitola P; Zotti M; Sancini G; Mauri M; Cagnotto A; Colombo L; Fiordaliso F; Grigoli E; Salmona M; Snellman A; Haaparanta-Solin M; Forloni G; Masserini M; Re F
J Neurosci; 2014 Oct; 34(42):14022-31. PubMed ID: 25319699
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease.
Mancini S; Balducci C; Micotti E; Tolomeo D; Forloni G; Masserini M; Re F
J Control Release; 2017 Jul; 258():121-129. PubMed ID: 28501671
[TBL] [Abstract][Full Text] [Related]
3. Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer's disease.
Park S; Kim HY; Oh HA; Shin J; Park IW; Yoon S; Woo DH; Kim Y
Sci Rep; 2021 Jun; 11(1):12043. PubMed ID: 34103615
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain.
Mazzitelli S; Filipello F; Rasile M; Lauranzano E; Starvaggi-Cucuzza C; Tamborini M; Pozzi D; Barajon I; Giorgino T; Natalello A; Matteoli M
Acta Neuropathol Commun; 2016 Oct; 4(1):110. PubMed ID: 27724899
[TBL] [Abstract][Full Text] [Related]
5. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
[TBL] [Abstract][Full Text] [Related]
6. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
[TBL] [Abstract][Full Text] [Related]
7. Aspartic Acid-Modified Phospholipids Regulate Cell Response and Rescue Memory Deficits in APP/PS1 Transgenic Mice.
Wang X; Gao H; Zhang X; Qian S; Wang C; Deng L; Zhong M; Qing G
ACS Chem Neurosci; 2022 Jul; 13(14):2154-2163. PubMed ID: 35818957
[TBL] [Abstract][Full Text] [Related]
8. Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.
Kim WS; Li H; Ruberu K; Chan S; Elliott DA; Low JK; Cheng D; Karl T; Garner B
J Neurosci; 2013 Mar; 33(10):4387-94. PubMed ID: 23467355
[TBL] [Abstract][Full Text] [Related]
9. In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer's disease pathology.
Trujillo-Estrada L; Jimenez S; De Castro V; Torres M; Baglietto-Vargas D; Moreno-Gonzalez I; Navarro V; Sanchez-Varo R; Sanchez-Mejias E; Davila JC; Vizuete M; Gutierrez A; Vitorica J
Acta Neuropathol Commun; 2013 Nov; 1():73. PubMed ID: 24252759
[TBL] [Abstract][Full Text] [Related]
10. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
11. Improvement of memory deficits and amyloid-β clearance in aged APP23 mice treated with a combination of anti-amyloid-β antibody and LXR agonist.
Fitz NF; Castranio EL; Carter AY; Kodali R; Lefterov I; Koldamova R
J Alzheimers Dis; 2014; 41(2):535-49. PubMed ID: 24643138
[TBL] [Abstract][Full Text] [Related]
12. Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.
Yang J; Ji Y; Mehta P; Bates KA; Sun Y; Wisniewski T
J Alzheimers Dis; 2011; 24(2):269-85. PubMed ID: 21239853
[TBL] [Abstract][Full Text] [Related]
13. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
14. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
15. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
Klein AN; Ziehm T; van Groen T; Kadish I; Elfgen A; Tusche M; Thomaier M; Reiss K; Brener O; Gremer L; Kutzsche J; Willbold D
ACS Chem Neurosci; 2017 Sep; 8(9):1889-1900. PubMed ID: 28581708
[TBL] [Abstract][Full Text] [Related]
16. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
17. An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice.
Cheng YS; Chen ZT; Liao TY; Lin C; Shen HC; Wang YH; Chang CW; Liu RS; Chen RP; Tu PH
EMBO Mol Med; 2017 May; 9(5):703-715. PubMed ID: 28356312
[TBL] [Abstract][Full Text] [Related]
18. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
[TBL] [Abstract][Full Text] [Related]
19. Intravenous treatment with a molecular chaperone designed against β-amyloid toxicity improves Alzheimer's disease pathology in mouse models.
Manchanda S; Galan-Acosta L; Abelein A; Tambaro S; Chen G; Nilsson P; Johansson J
Mol Ther; 2023 Feb; 31(2):487-502. PubMed ID: 35982621
[TBL] [Abstract][Full Text] [Related]
20. A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis.
Xue D; Zhao M; Wang YJ; Wang L; Yang Y; Wang SW; Zhang R; Zhao Y; Liu RT
Neurobiol Dis; 2012 Jun; 46(3):701-9. PubMed ID: 22426388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
